FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine
The US Food and Drug Administration (FDA) has approved an intranasal formulation of dihydroergotamine mesylate (DHE) for the acute treatment
Read more
Intranasal DHE Safe for Acute Migraine: STOP 301 Published
An intranasal formulation of dihydroergotamine (DHE) for the acute treatment of migraine is safe and well tolerated, new research suggests.
Read more
Intranasal Third-Generation CGRP Effective for Acute Migraine
Intranasal zavegepant, a third-generation calcitonin gene-related peptide (CGRP) receptor agonist, is effective and well tolerated in the treatment of acute
Read more
Genetic malfunction of brain astrocytes triggers migraine
Neuroscientists of the University of Zurich shed a new light on the mechanisms responsible for familial migraine: They show that
Read more
Too much coffee raises the odds of triggering a migraine headache
Drinking three or more servings of caffeinated beverages a day is associated with the onset of a headache on that
Read more
Migraine – the Problem with the painkillers
Chinese medicine also helps in hopeless cases Throbbing, pounding or stabbing, mainly half-sided pain in the head, more and more
Read more
15 natural and home remedies for migraine relief
In America, the Migraine Research Foundation estimate that almost 12 percent of people suffer from migraine headaches. Migraine headaches are
Read more